Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Switzerland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20042
20054
20061
20071
20101
20122
20131
20151
20171
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting3
Terminated2
No longer available1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Bristol-Myers Squibb5
Children's Oncology Group2
Ariad Pharmaceuticals1
European Society for Blood and Marrow Transplantation1
Heidelberg University1
III. Medizinische Klinik Mannheim1
Takeda1
University of Jena1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive22
Leukemia7
Leukemia, Myeloid, Chronic-Phase4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Bone Marrow Diseases3
Leukemia, Myeloid3
Myeloproliferative Disorders3
Philadelphia Chromosome3
Blast Crisis2
Hematologic Diseases2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.